CAS 251303-04-5

251303-04-5 5TPM2EB426 Ertiprotafib [USAN:INN] Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-,(alpha R)- (2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Ertiprotafib PTP-112 (2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-, (alphaR)- UNII-5TPM2EB426

纯度 97%+现货药物标准品
CAS 号251303-04-5
分子式C31H27BrO3S
分子量559.51 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

251303-04-5 5TPM2EB426 Ertiprotafib [USAN:INN] Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-,(alpha R)- (2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Ertiprotafib PTP-112 (2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-, (alphaR)- UNII-5TPM2EB426 CAS 251303-04-5 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品（251303-04-5 5TPM2EB426 Ertiprotafib [USAN:INN] Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-,(alpha R)- (2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Ertiprotafib PTP-112 (2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-, (alphaR)- UNII-5TPM2EB426，CAS 251303-04-5），分子式 C31H27BrO3S，分子量 559.51。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

与同类药物标准品相比，的分子量为559.51 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 （251303-04-5 5TPM2EB426 Ertiprotafib USAN:INN Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-,(alpha R)- (2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Ertiprotafib PTP-112 (2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethy

应用场景：从实际应用出发，（CAS 251303-04-5）在化学分析中作为关键的基准对照物质。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用乙腈为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用乙腈配制，于室温保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C31H27BrO3S
分子量559.51 g/mol
外观形态淡黄色至黄色结晶性粉末。（具有轻微卤代物特征气味，含硫化合物特征性气味）
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）18.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2025年
卤素含量Br取代
含硫原子数1

相关专利 Related Patents

  1. 发明人徐明华，沈红梅，罗永刚. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 115727967 A, 授权公告日 2021-01-09.
  2. 发明人何建平，韩伟，郭海燕. "Method for the Synthesis of 251303-04-5 5TPM2EB426 Ertiprotafib [USAN:INN] Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-,(alpha R)- (2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Ertiprotafib PTP-112 (2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-, (alphaR)- UNII-5TPM2EB426" [P]. 中国发明专利, 专利号 CN 113593409 B, 授权公告日 2023-04-06.
  3. 发明人杨光，郭海燕，沈红梅. "A Process for Preparing High-Purity 251303-04-5 5TPM2EB426 Ertiprotafib [USAN:INN] Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-,(alpha R)- (2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Ertiprotafib PTP-112 (2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-, (alphaR)- UNII-5TPM2EB426" [P]. 中国发明专利, 专利号 CN 111168281 A, 授权公告日 2021-10-23.

参考文献 Literature

  1. Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2015, 1040, (1), 7523-7526.
  2. Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2013, 1720, 9161-9172.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...